Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Lenalidomide in Combination with Nivolumab In Patients with Relapsed/Refractory MM

Protocol: OSU-17160

Full Title

Phase II Study of Lenalidomide in Combination with Nivolumab In Patients with Relapsed/Refractory Multiple Myeloma

Multiple Myeloma